1. Allen, J. C. (1976). Infection complicating neoplastic disease and cytotoxic therapy. In Allen, J. C. (ed.) Infection and the Compromised Host, pp. 151–171. (Baltimore: Williams & Wilkins Company)
2. Lachmann, P. J. and Rosen, F. S. (1978). Genetic defects of complement in man. In Miescher, P. A. and Mueller-Eberhard, H. J. (eds.) Springer Semin. Immunopathol., 1, p. 339
3. Pahwa, R., Pahwa, S., O’Reilly, R. and Good, R. (1978). Treatment of the immunodeficiency diseases — progress towards replacement therapy emphasizing cellular and macromolecular engineering. In Miescher, P. A. and Mueller-Eberhard, J. J. (eds.) Springer Semin. Immunopathol., 1, p. 355
4. Quie, P. G., Mills, E. L., McPhail, L. C. and Johnston, R. B. (1978). Phagocytic defects. In Miescher, P. A. and Mueller-Eberhard, H. J. (eds.) Springer Semin. Immunopathol., 1, pp.323–337
5. Esplin, D. W. and Marcus, S. (1954). Relation between antibacterial action of penicillin and mouse host defenses in systemic pneumococcus infection. Antibiot. Chemother., 4, 123